Ovascience (OVAS) Misses Q4 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
OvaScience (OVAS) Bullish Stance Reiterated at Leerink Partners Post Q4
March 17, 2015 6:35 AM EDTLeerink Partners analyst Gena Wang reiterated an Outperform rating and $56 price target on OvaScience (NASDAQ: OVAS) following Q4 results, noting the AUGMENT commercial launch is on track, with pipeline assets providing upside.
Wang commented, "While no commercial cycles reported in 4Q:14,... More
